Clinical Trial Update: PRIMA US-Feasibility Study in Atrophic Dry AMD [NA]

View source ↗

Summary

The PRIMA US feasibility study for atrophic dry age-related macular degeneration is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Age-related Macular Degeneration

Snippet

Sponsor: Science Corporation | Conditions: Dry Age-related Macular Degeneration | NA | Status: ACTIVE_NOT_RECRUITING